Abstract
Nanomedicine has emerged as a revolutionary approach in drug delivery systems, offering unprecedented specificity and efficacy in targeting diseased tissues, particularly in cancer therapy. The integration of nanotechnology in medicine has enabled the design of nano-carriers that improve pharmacokinetics, enhance bioavailability, and minimize systemic toxicity. This article explores recent advancements in nanomedicine, focusing on nanoformulations such as liposomes, dendrimers, and polymeric nanoparticles. The applications of nanomedicine in targeted drug delivery, current challenges, and potential future directions are also discussed.
All articles published in the American Journal of Pharmacy and Pharmacology are licensed under the Creative Commons Attribution 4.0 International License (CC BY 4.0). This license allows others to:
-
Share — copy and redistribute the material in any medium or format
-
Adapt — remix, transform, and build upon the material for any purpose, even commercially
Under the following terms:
-
Attribution — Appropriate credit must be given to the original author(s) and source, a link to the license must be provided, and any changes made must be indicated.
By submitting their work, authors agree to these licensing terms and retain copyright of their articles.